Page 126 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 126
Liver Transplantation / Surgery: Clinical (Cont.)
P0040 LONG-TERM CARDIOVASCULAR MORTALITY AFTER
LIVER TRANSPLANTATION: ANALYSIS OF RISK FACTORS
Delia D'Avola*, Valentín Cuervas-Mons, Josep Martí,
Jorge Ortiz de Urbina , Laura Lladó, Carlos Jimenez, Esteban Otero,
Francisco Suarez, Juan Miguel Rodrigo, Miguel Angel Gomez,
Enrique Fraga, Pedro Lopez, Trinidad Serrano, Antonio Rios,
Emilio Fabrega, José Ignacio Herrero, Spain
P0041 THE IMPACT OF DONOR AND RECIPIENTS SINGLE
NUCLEOTIDE POLYMORPHISMS OF LIVER FIBROSIS
PROGRESSION IN LIVING LIVER TRANSPLANTATION FOR
HEPATITIS C
Hisamitsu Miyaaki*, Tatsuki Ichikawa, Naota Taura, Satoshi Miuma,
Hidetaka Shibata, Takuya Honda, Kauhiko Nakaoa, Japan
P0042 SAFETY AND EFFICACY OF SOFOSBUVIR AND
SIMEPREVIR TREATMENT IN HEPATITIS C GENOTYPE
ePOSTERS 1 LIVER TRANSPLANT RECIPIENTS WITH ADVANCED
FIBROSIS/ RECURRENT CIRRHOSIS
Andres F. Carrion, Adam Peyton, Danny Avalos, Eric Martin,
Julio Gutierrez, Christopher O’Brien, Paul Martin,
Kalyan R. Bhamidimarri*, The United States
P0043 RATE OF EMPLOYMENT AFTER LIVER TRANSPLANTATION
IN FRANCE: A SINGLE CENTRE STUDY
Marika Rudler*, Géraldine Rousseau, Pascal Lebray, Jean-
Christophe Vaillant, Eric Savier, Daniel Eyraud, Thierry Poynard,
Dominique Thabut, France
P0044 MRCP TAKEN ONE MONTH AFTER LDLT MAY PREDICT
BILIARY COMPLICATION
Soonkyu Lee*, Jong Young Choi, South Korea
P0045 LONG TERM LOW DOSE STEROID TRIPLE
IMMUNOSUPPRESSIVE REGIMENS IN POST TRANSPLANT
AUTOIMMUNE HEPATITIS (AIH) PATIENTS REDUCES
THE INCIDENCE OF RECURRENT DISEASE AND IS NOT
ASSOCIATED WITH INCREASED MORTALITY
Thinesh L. Krishnamoorthy*, Joanna Miezynska-Kurtycz, James Hodson,
Bridget K. Gunson, James Neuberger, Piotr Milkiewicz,Ye H. Oo,
Singapore
126 The International Liver Congress™ 2015 • ILC Programme
P0040 LONG-TERM CARDIOVASCULAR MORTALITY AFTER
LIVER TRANSPLANTATION: ANALYSIS OF RISK FACTORS
Delia D'Avola*, Valentín Cuervas-Mons, Josep Martí,
Jorge Ortiz de Urbina , Laura Lladó, Carlos Jimenez, Esteban Otero,
Francisco Suarez, Juan Miguel Rodrigo, Miguel Angel Gomez,
Enrique Fraga, Pedro Lopez, Trinidad Serrano, Antonio Rios,
Emilio Fabrega, José Ignacio Herrero, Spain
P0041 THE IMPACT OF DONOR AND RECIPIENTS SINGLE
NUCLEOTIDE POLYMORPHISMS OF LIVER FIBROSIS
PROGRESSION IN LIVING LIVER TRANSPLANTATION FOR
HEPATITIS C
Hisamitsu Miyaaki*, Tatsuki Ichikawa, Naota Taura, Satoshi Miuma,
Hidetaka Shibata, Takuya Honda, Kauhiko Nakaoa, Japan
P0042 SAFETY AND EFFICACY OF SOFOSBUVIR AND
SIMEPREVIR TREATMENT IN HEPATITIS C GENOTYPE
ePOSTERS 1 LIVER TRANSPLANT RECIPIENTS WITH ADVANCED
FIBROSIS/ RECURRENT CIRRHOSIS
Andres F. Carrion, Adam Peyton, Danny Avalos, Eric Martin,
Julio Gutierrez, Christopher O’Brien, Paul Martin,
Kalyan R. Bhamidimarri*, The United States
P0043 RATE OF EMPLOYMENT AFTER LIVER TRANSPLANTATION
IN FRANCE: A SINGLE CENTRE STUDY
Marika Rudler*, Géraldine Rousseau, Pascal Lebray, Jean-
Christophe Vaillant, Eric Savier, Daniel Eyraud, Thierry Poynard,
Dominique Thabut, France
P0044 MRCP TAKEN ONE MONTH AFTER LDLT MAY PREDICT
BILIARY COMPLICATION
Soonkyu Lee*, Jong Young Choi, South Korea
P0045 LONG TERM LOW DOSE STEROID TRIPLE
IMMUNOSUPPRESSIVE REGIMENS IN POST TRANSPLANT
AUTOIMMUNE HEPATITIS (AIH) PATIENTS REDUCES
THE INCIDENCE OF RECURRENT DISEASE AND IS NOT
ASSOCIATED WITH INCREASED MORTALITY
Thinesh L. Krishnamoorthy*, Joanna Miezynska-Kurtycz, James Hodson,
Bridget K. Gunson, James Neuberger, Piotr Milkiewicz,Ye H. Oo,
Singapore
126 The International Liver Congress™ 2015 • ILC Programme
